KUREKraneShares MSCI All China Health Care Index ETF
Seeks to provide investment results that track the price and yield performance of the MSCI China All Shares Health Care 10/40 Index.
By KraneShares · Launched 2018
Annual Cost
0.65%
#3,297 of 5,562 · average
Fund Size
$73M
#3,217 of 5,562 · mid-size
Return (1Y)Goal
-9.3%
Track Record
8 years
#1,705 of 5,562 · established
Performance
Total-return NAV · USDGrowth of $10,000
$9,121-8.8%
Total-return NAV, USD. Net of fund fees, before tax.
Classification
How Beacon categorizes this fundAsset class
EquityRegion
Asia pacificCap
Multi cap
Strategy
Index tracking
Sector
Health careIndex tracked
MSCI China All Shares Health Care 10/40 Index
What it actually holds
By weightConcentration
Top 10 holdings = 55.3% of fundmoderately concentrated
BeOne Medicines AG
8.4%
Jiangsu Hengrui Pharmaceuticals Co.,Ltd
8.3%
INNOVENT BIOLOGICS, INC.
7.2%
WUXI BIOLOGICS (CAYMAN) INC.
7.0%
Akeso Inc
4.7%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
4.5%
CSPC PHARMACEUTICAL GROUP LIMITED
4.4%
SINO BIOPHARMACEUTICAL LIMITED
4.1%
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED
3.5%
WuXi AppTec Co., Ltd.
3.2%
Asset allocation
Stocks
99.1%
Cash
0.9%
By sector
Healthcare
99.3%
Consumer Defensive
0.7%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
26.2%High
Year-on-year price swings
Max drawdown
-68.5%Severe
Worst peak-to-trough loss
Sharpe (3Y)
-0.19Below average
Sortino (3Y)
-0.26Moderate downside risk
Where to buy
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks to provide investment results that track the price and yield performance of the MSCI China All Shares Health Care 10/40 Index.
- Strategy
- Invests primarily in securities of the MSCI China All Shares Health Care 10/40 Index, including A-Shares, B-Shares, and H-Shares. May use representative sampling to track the index.
- Inception date
- January 31, 2018
- Fund family
- KraneShares
Similar ETFs
Closest matches by profileWhat's next?
You've reviewed KURE. Save it to your watchlist to track it alongside the other funds you're weighing.
Data updated on 2026-06-19